Baseline clinical features but not TLL1 variants predicts HCC onset in Caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years
Titel:
Baseline clinical features but not TLL1 variants predicts HCC onset in Caucasian compensated HBV cirrhotics treated by Entecavir or Tenofovir for 8 years
Auteur:
Loglio, A. Galmozzi, E. Iavarone, M. Grossi, G. ViganĂ², M. Facchetti, F. Perbellini, R. Rumi, M.G. Sangiovanni, A. Lampertico, P.